DefinitionThis section has been translated automatically.
Virustatic. Inhibitor of HIV protease.
IndicationThis section has been translated automatically.
Antiretroviral combination therapy for the treatment of HIV-1 infection in experienced patients, in particular those pre-treated with protease inhibitors.
Notice!
Consideration of the viral resistance pattern and pretreatment of the patient, especially with other protease inhibitors!You might also be interested in
Pregnancy/nursing periodThis section has been translated automatically.
Contraindicated during pregnancy and lactation (insufficient data available).
Dosage and method of useThis section has been translated automatically.
Adults > 18 years: once/day 400 mg p.o.In combination with ritonavir : once/day 300 mg p.o.
Undesirable effectsThis section has been translated automatically.
Diarrhea, headache, reversible hyperbilirubinemia (icterus)
ContraindicationThis section has been translated automatically.
Hypersensitivity to the substance, comedication with benzodiazepines (midazolam, triazolam), ergotamine derivatives, cisapride, neuroleptics.
PreparationsThis section has been translated automatically.
Reyataz
Prof. Dr. med. Peter Altmeyer